Sample banner

Acting Director KEMRI, Dr. Gerald Mkoji and the Chairman of the KEMRI Board of Management, Dr. Naftali Agata append their signatures on the Performance Contract document on Tuesday, February 28th, 2017, as Mr. Phillip Melly from the Institute’s Monitoring & Evaluation Unit looks on.


Three KEMRI researchers are among 22 early career scientists from the African continent who have been recognised by the African Academy of Sciences (AAS). Dr. Damaris Matoke, Prof. Mwangi Thumbi and Dr Melissa Kapulu are part of the 22 scientists were selected through a merit based review process from five African regions to be AAS Affiliates from 2017 to 2021.

Dr. Matoke works at the Institute’s Center for Biotechnology Research and Development, while Prof. Thumbi is from the Kisumu-based, Center for Global Health Research. Dr. Kapulu is a Zambia-born postdoctoral fellow at the KEMRI-Wellcome Trust Programme.

While congratulating the three for their achievement, Acting Director KEMRI, Dr. Gerald Mkoji noted that their exemplary efforts that put the Institute on a global limelight.

Read More on the following links





Upcoming Events


04.25.2017 7:00 am - 5:00 pm

KEMRI Polio Laboratory is Rated Excellent

Sample image

The KEMRI Polio Laboratory has received two prestigious international recognitions for its continued professional proficiency and adherence to quality tests and results.

A Netherlands-based Specialized Reference Laboratory for Polio (RIVM) under the Polio Global Eradication Initiative gave the Laboratory a perfect score of 100 percent.

In the WHO Global Polio Laboratory Network (GPLN),Virus Isolation Proficiency Testing 2016-1 carried out towards the end of 2016.


New guidelines on HIV self-testing released

Sample image

Lack of effective HIV diagnosis has grossly hampered the fight against HIV, the World Health Organization (WHO) has said.

Consequently, as the World Aids Day is observed today, the WHO, has released new guidelines on HIV self-testing aimed at improving access to and uptake of HIV diagnosis

In a special report released Tuesday, 29th November, 2016, reveals that more than 18 million people with HIV are currently taking ART


KEMRI on Twitter

KEMRI on Facebook

Research Programmes

  • Biotechnology. jpg.jpg
  • Infectious and Parasitic Disease.jpg.jpg
  • natural products.jpg
  • Non- Communicable.jpg
  • Public Health and Health Systems jpg.jpg
  • Sexual, Reproductive, Adolesent & Child Health. jp.jpg

KEMRI has six (6) Main Programmes aligned to the KEMRI Strategic Master plan and the Vision 2030.

Upcoming Events

Sample image

The 7th KASH Conference, scheduled for February 8th-10th, 2017, Nairobi.

KEMRI Milestones

KEMRI has developed immense capacity in carrying out world class research through development of infrastructure and human capacity

Ebola Virus

Sample image

Researchers at the Kemri-wellcome trust in Kilifi Kenya have completed the enromllment in a trial of a vaccine designed to protect against ebola.